Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Apyx Medical (APYX) Return on Sales (2016 - 2025)

Apyx Medical (APYX) has disclosed Return on Sales for 15 consecutive years, with 0.06% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Return on Sales fell 155.0% year-over-year to 0.06%, compared with a TTM value of 0.21% through Dec 2025, down 26.0%, and an annual FY2025 reading of 0.21%, down 26.0% over the prior year.
  • Return on Sales was 0.06% for Q4 2025 at Apyx Medical, up from 0.15% in the prior quarter.
  • Across five years, Return on Sales topped out at 1.48% in Q4 2024 and bottomed at 0.74% in Q1 2024.
  • Average Return on Sales over 5 years is 0.31%, with a median of 0.4% recorded in 2023.
  • The sharpest move saw Return on Sales soared 214bps in 2024, then plummeted -155bps in 2025.
  • Year by year, Return on Sales stood at 0.12% in 2021, then plummeted by -303bps to 0.48% in 2022, then crashed by -36bps to 0.66% in 2023, then skyrocketed by 326bps to 1.48% in 2024, then tumbled by -104bps to 0.06% in 2025.
  • Business Quant data shows Return on Sales for APYX at 0.06% in Q4 2025, 0.15% in Q3 2025, and 0.33% in Q2 2025.